Effects of ertugliflozin monotherapy or combination therapy on glycaemic control, body weight, and blood pressure in patients with type 2 diabetes: a pooled analysis

被引：0
|
作者：
Lauring, B. [1 ]
Liu, J. [1 ]
Tarasenko, L. [2 ]
Terra, S. G. [3 ]
Huyck, S. [1 ]
Wu, L. [1 ]
Pong, A. [1 ]
Calle, R. A. [4 ]
Gallo, S. [5 ]
Darekar, A. [6 ]
Mancuso, J. P. [7 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Andover, MA USA
[4] Pfizer Inc, Cambridge, MA USA
[5] Pfizer Pharma GmbH, Berlin, Germany
[6] Pfizer Ltd, Walton Oaks, England
[7] Pfizer Inc, Groton, CT 06340 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
628
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [41] Association between continuous positive airway pressure, weight change and glycaemic control in patients with type 2 diabetes
    Schaller, Louisa
    Arzt, Michael
    Jung, Bettina
    Boeger, Carsten A.
    Heid, Iris M.
    Stadler, Stefan
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [42] Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes
    Wainstein, J.
    Katz, L.
    Engel, S. S.
    Xu, L.
    Golm, G. T.
    Hussain, S.
    O'Neill, E. A.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2012, 14 (05): : 409 - 418
  • [43] Glycaemic control and weight loss with semaglutide in type 2 diabetes
    Madsbad, Sten
    Holst, Jens J.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 315 - +
  • [44] Glycaemic control in type 2 diabetes:: the impact of body weight,: β-cell function and patient education
    Chan, WB
    Chan, JCN
    Chow, CC
    Yeung, VTF
    So, WY
    Li, JKY
    Ko, GTC
    Ma, RCW
    Cockram, CS
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2000, 93 (03): : 183 - 190
  • [45] Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
    Stenberg, Erik
    Cao, Yang
    Ottosson, Johan
    Hedberg, Suzanne
    Naslund, Erik
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5812 - 5818
  • [46] Arterial stiffness in patients with type 2 diabetes correlates with both ambulatory and central blood pressure but not with glycaemic control
    Wijkman, M.
    Lanne, T.
    Engvall, J.
    Lindstrom, T.
    Ostgren, C. J.
    Nystrom, F.
    JOURNAL OF HYPERTENSION, 2007, 25 : S274 - S274
  • [47] Impact of linagliptin therapy in patients with Type 2 diabetes and suboptimal glycaemic control
    Holland, A. L.
    Gururaj, S.
    Lawrence, I.
    DIABETIC MEDICINE, 2014, 31 : 182 - 183
  • [48] Effects of beta(2)-agonist therapy on blood pressure, glycaemic control and electrolytes levels of asthmatic patients
    Lutfi, Mohamed Faisal
    SUDAN JOURNAL OF MEDICAL SCIENCES, 2011, 6 (02): : 69 - 74
  • [49] Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis
    Khunti, Kamlesh
    Ceriello, Antonio
    Cos, Xavier
    De Block, Christophe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 137 - 148
  • [50] Effects of Pioglitazone and Metformin Combination Therapy on High-Molecular-Weight Adiponectin Compared With Metformin Monotherapy in Type 2 Diabetes Mellitus Patients
    Matsushita, Takaya
    Kaji, Akino
    Kaji, Kuniaki
    Takahashi, Eri
    Usui, Takahiro
    Asahi, Nobuteru
    Sato, Tomoya
    Ohono, Atushi
    Ueki, Akio
    DIABETES, 2012, 61 : A626 - A626
12345